Table 5.
L/D shifts | Rat | Mouse | Total | Studies |
---|---|---|---|---|
Bodyweight | 2/5 | 3/4 | +: 4/9 (44, 4%) | Vilaplana et al., 1995; Tsai et al., 2005; Bartol-Munier et al., 2006; Oishi, 2009; Gale et al., 2011; Karatsoreos et al., 2011; Oishi and Itoh, 2013; Voigt et al., 2014 |
−: 1/9 (11, 1%) | ||||
o: 4/9 (44, 4%) | ||||
Food intake total | 2/3 | 1/3 | +: 2/6 (33, 3%) | Vilaplana et al., 1995; Tsai et al., 2005; Bartol-Munier et al., 2006; Oishi, 2009; Karatsoreos et al., 2011; Oishi and Itoh, 2013 |
−: 1/6 (16, 7%) | ||||
o: 3/6 (50%) | ||||
Activity total | 2/2 | +: 0/2 (0%) | Tsai et al., 2005; Bartol-Munier et al., 2006 | |
−: 2/2 (100%) | ||||
o: 0/2 (0%) | ||||
EE total | ||||
RER | ||||
Adiposity | ||||
Glucose metabolism | 2/3 | 3/3 | +: 4/6 (66, 7%) | Bartol-Munier et al., 2006; Oishi, 2009; Gale et al., 2011; Karatsoreos et al., 2011; Oishi and Itoh, 2013 |
−: 1/6 (16, 7%) | ||||
~: 0/6 (0%) | ||||
o: 1/6 (16, 7%) | ||||
Lipid metabolism | 0/1 | 1/2 | +: 1/3 (33, 3%) | Bartol-Munier et al., 2006; Oishi, 2009; Oishi and Itoh, 2013 |
−: 0/3 (0%) | ||||
~: 0/3 (0%) | ||||
o: 2/3 (66, 7%) | ||||
Corticosterone | ||||
Melatonin | 2/2 | +: 0/2 (0%) | Gale et al., 2011 | |
−: 0/2 (0%) | ||||
~: 2/2 (100%) | ||||
o: 0/2 (0%) | ||||
Leptin | 1/1 | +: 1/1 (100%) | Karatsoreos et al., 2011 | |
−: 0/1 (0%) | ||||
~: 0/1 (0%) | ||||
o: 0/1 (0%) | ||||
Ghrelin | ||||
BP/Heart rate | 1/1 | +: 0/1 (0%) | Tsai et al., 2005 | |
−: 0/1 (0%) | ||||
~: 1/1 (100%) | ||||
o: 0/1 (0%) | ||||
Gene expression | 1/1 | 1/1 (100%) | Oishi and Itoh, 2013 |
For detailed description of the columns, see Methods section.
+, number of studies with increases; −, number of studies with decreases; ~, number of studies with altered rhythm; o, number of studies with no effect. For glucose metabolism a + indicates increased basal levels of glucose, HbA1c or insulin, increased HOMA index or decreased glucose tolerance.
EE, energy expenditure; RER, respiratory exchange ratio; BP, blood pressure.